The Impact of CT Reconstruction Parameters on Emphysema Index Quantification, HU-Based Measurements, and Goddard Score in COPD Assessment: A Prospective Study

CT重建参数对慢性阻塞性肺疾病评估中肺气肿指数量化、基于HU值的测量和Goddard评分的影响:一项前瞻性研究

阅读:2

Abstract

BACKGROUND: Quantitative computed tomography (CT) plays a crucial role in assessing emphysema severity in chronic obstructive pulmonary disease (COPD). However, variations in CT reconstruction parameters-slice thickness (ST), kernel selection, field of view (FOV), and reconstruction gaps-can affect emphysema index (EI) quantification, impacting diagnostic accuracy and study comparability. OBJECTIVE: This study examines how CT reconstruction parameters influence EI quantification using Hounsfield Unit (HU)-based measurements and the Goddard Score (GS) to refine imaging protocols for emphysema assessment. METHODS: Low-dose CT scans were performed on 31 subjects, with images reconstructed using ST (0.6-10 mm), kernel settings (Br and Hr series), FOV ranges (250-370 mm), and reconstruction gaps (0.25-3 mm). EI was defined as the percentage of lung volume with attenuation values below - 950 HU, while GS provided a semi-quantitative assessment of emphysema severity. Statistical analyses evaluated the effects of reconstruction parameters on EI and GS. RESULTS: Variations in FOV, kernel selection, and reconstruction gaps had negligible effects on the GS (p > 0.05), suggesting that these parameters do not introduce structural distortions in pulmonary imaging. However, ultra-thin slices (0.6 mm) enhanced the detection of subtle emphysematous changes, slightly increasing GS, though higher image noise may affect interpretation. Additionally, ST significantly influenced EI values due to partial volume effects, with thinner slices yielding lower attenuation values. CONCLUSION: These findings confirm the reliability of CT-based emphysema quantification and highlight the importance of optimizing ST to balance sensitivity and image clarity. Standardized imaging protocols and AI-driven texture analysis could further enhance quantitative emphysema assessment, improving disease monitoring and therapeutic decision-making in COPD management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。